Berlin Metropolitan Area
Experienced Lab Head with history of working in pharma industry since 2005. Strong research professional skills in Arthritis (RA, PsA), IBD,Psoriasis, Atopic Dermatitis, MS and SLE (in vivo & in vitro). Project leadership. Coping with multiple interfaces (e.g. clinical development, commercial, legal, chemistry). Team lead experience >19 years.
- in vitro & in vivo characterization of several drug development candidates (small molecules & biologics) with focus on autoimmune diseases, such as Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Psoriasis, Multiple Sclerosis and SLE - project leadership (from preclinical target validation up to start of clinical development) - pharmacology representative in Global Project Teams, Early Clinical Teams, Due Diligences, Target Product Profile generation - dealing with multiple interfaces (clinical development, commercial, etc.) and external networks (e.g. CROs, KOLs) - leadership of animal experiments - team lead of lab technicans, students and trainees
- identification of new targets (biologics) for the treatment of Inflammatory Bowel Disease - antibody evaluation in in vivo models of inflammation and IBD - establishment of in vitro antibody screening assays and of new in vivo models - management of collaborations with external partners - leadership of lab technicans, students and trainees
- identification of new potential indications for drugs in development pipeline - target evaluation (in vivo & in vitro) of small molecules for treatment of Inflammatory Bowel Disease - establishment of in vivo models for IBD or pharmacodynamic models - leadership of lab technicans, students and trainees - leadership of animal experiments - management of collaborations
establishment of novel in vitro & in vivo models, characterization of drug candidates in different inflammation models related to dermatology (psoriasis, atopic dermatitis)
PhD in Immunology/Infection Biology (Interleukin-15, Immunity to Mycobacterium tuberculosis, vaccination studies, T cell immunity)